Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

'Failed' experiment yields a biocontrol agent that doesn't trigger antibiotic resistance

06.10.2006
A failed experiment turned out to be anything but for bacteriologist Marcin Filutowicz.

As he was puzzling out why what should have been a routine procedure wouldn't work, he made a discovery that led to the creation of a new biological tool for destroying bacterial pathogens - one that doesn't appear to trigger antibiotic resistance.

The discovery also led to the startup of a promising new biotechnology firm that has already brought Wisconsin a dozen new, high-paying, highly skilled jobs. Filutowicz is a professor of bacteriology in the University of Wisconsin-Madison College of Agricultural and Life Sciences.

His inspiration came one morning in 1999 when he was puzzling over a failed experiment. A researcher in his lab had been trying to insert two different mutations into an ordinary bacterial plasmid - a routine task for the experienced scientist - but every attempt failed to produce a live bacterium.

Plasmids are circular DNA molecules that are different from chromosomal DNA, the genetic material that encodes the instructions for life in all cells. Plasmids are small, non-chromosomal DNA molecules. They are common in bacteria. The genes in plasmids often encode information that confers some selective advantage to their hosts - such as the ability to resist antibiotics.

Plasmids are useful tools for genetic engineering. It is relatively easy for a scientist to alter a plasmid's genetic makeup and then transfer the plasmid into a bacterium. The host bacterium then replicates the recombinant plasmid and transfers copies of it to other bacteria in a process called conjugation.

As he investigated the failed experiment, Filutowicz - who has spent two decades studying how plasmid replication is regulated - made a critical observation. A plasmid with one or the other of the benign mutations persisted, although it replicated a little more frequently than a mutation-free plasmid. How could it be, he wondered, that a bacteria with both mutations could not survive? The professor surmised that when the two mutations were brought together, the plasmid carrying them became harmful by over-replicating within the bacterium, ultimately destroying it.

"And I thought, this is very cool!" recalls Filutowicz. "I didn't observe any survival or further resistance to over-replication, even though typically when bacteria are exposed to harmful agents like antibiotics, resistant strains emerge. Nothing with the killer plasmid survived."

The next step was to engineer a strain of bacteria that could suppress over-replication of the key plasmid. This so-called "Trojan horse" could then be used to spread the killer plasmid via conjugation to targeted bacterial pathogens that lacked the ability to resist over-replication.

"We harnessed this plasmid," thought Filutowicz. "Now, how can we use it?" The answer came in 1999, when he filed a disclosure through the Wisconsin Alumni Research Foundation, which patents the discoveries of UW-Madison researchers and licenses technology to industry. Filutowicz believed so strongly in the potential of the basic work done in his lab that he, along with professor of oncology Richard Burgess, started a company called ConjuGon - "because you conjugate and it's gone!" -- to develop the technology and ultimately bring it to human trials, which are currently planned for 2007 or 2008. A patent for his discovery has just been issued.

"We see a broad application for this work," he explains. "We can build things that don't exist in nature. It's a versatile concept that doesn't apply to just one antimicrobial agent."

Filutowicz and Burgess, wine enthusiasts who are as comfortable fermenting grapes as they are transforming bacterial plasmids, partnered with students from the Weinert Applied Ventures Program at the UW-Madison School of Business to develop a plan for ConjuGon. One of the students, Sal Braico, ultimately became Chief Operating Officer of the company. "Sal learned about biology and got experience with a start-up, and Dick and I got business expertise. It was a great partnership," Filutowicz says.

In addition to federal funding from the National Science Foundation and the Department of Defense, the company has also attracted so-called angel funding from outside investors. Filutowicz and Burgess are not on the payroll of the research park company themselves, but they are proud that ConjuGon employs other people and has created 12 high-paying and highly skilled jobs for the Madison area.

Because of that, says Filutowicz, ConjuGon is helping to ensure the future of microbial sciences at the UW-Madison.

"We have one of the largest and most prominent communities of microbiologists in the country on the UW-Madison campus," he says. "It's important to provide jobs and opportunities in Madison for people who train here."

And beyond helping to expand Wisconsin's booming biotechnology sector, success at ConjuGon will ultimately help nurture future scientific innovations from the university.

"Because WARF is the licensor of my patent, and the company is a licensee, ConjGon, if successful, will ultimately support more UW research," Filutowicz explains.

A powerful, long-reaching impact - all from an idea that originated in a failed experiment.

Marcin Filutowicz | EurekAlert!
Further information:
http://www.wisc.edu

Further reports about: ConjuGon Filutowicz Plasmid UW-Madison antibiotic mutations

More articles from Life Sciences:

nachricht The irresistible fragrance of dying vinegar flies
16.08.2017 | Max-Planck-Institut für chemische Ökologie

nachricht How protein islands form
15.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

Im Focus: Scientists improve forecast of increasing hazard on Ecuadorian volcano

Researchers from the University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science, the Italian Space Agency (ASI), and the Instituto Geofisico--Escuela Politecnica Nacional (IGEPN) of Ecuador, showed an increasing volcanic danger on Cotopaxi in Ecuador using a powerful technique known as Interferometric Synthetic Aperture Radar (InSAR).

The Andes region in which Cotopaxi volcano is located is known to contain some of the world's most serious volcanic hazard. A mid- to large-size eruption has...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New thruster design increases efficiency for future spaceflight

16.08.2017 | Physics and Astronomy

Transporting spin: A graphene and boron nitride heterostructure creates large spin signals

16.08.2017 | Materials Sciences

A new method for the 3-D printing of living tissues

16.08.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>